SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001567619-19-012686
Filing Date
2019-06-04
Accepted
2019-06-04 16:52:13
Documents
1
Group Members
BAUPOST GROUP GP, L.L.C.SETH A. KLARMAN

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13D/A 181701
  Complete submission text file 0001567619-19-012686.txt   183269
Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Filed by) CIK: 0001061768 (see all company filings)

IRS No.: 043402144 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83422 | Film No.: 19877310
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences